Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes

作者: Nitya G. Chakraborty , Jonathan R. Sporn , Dominick R. Pasquale , M.T. Ergin , Bijay Mukherji

DOI: 10.1016/0090-1229(91)90036-A

关键词:

摘要: Abstract A functional analysis of tumor-infiltrating lymphocytes (TILs) from renal cell carcinoma (RCC) and malignant melanoma was performed. TILs were expanded in recombinant interleukin-2 (50 U/ml) Iscoves medium. Phenotypic (cytolytic vs regulatory) analyses carried out with the fresh TIL populations after 4 weeks culture. Only one population an RCC case (out six cases studied) CD8+ demonstrated MHC class I-restricted tumor-specific cytotoxicity against autologous target. other five became predominantly CD4+ they neither killed respective tumor cells nor NK-sensitive target K-562 cells. When studied for functions, two found to suppress lymphokine-activated killer response by peripheral blood (PBL) coculture. Of these two, a (MJ TIL) used study cellular molecular mechanisms suppression. The MJ synthesized supernatant factor that blocked activation resting PBL as measured induction high-affinity IL-2 receptor (IL-2R) when stimulated phytohemagglutinin but did not down-regulate fully expressed IL-2R on activated T suppression result necrosis factor-α β or transforming growth factor-β cytokines detected cell-free also suppressed IL-2-mediated enhancement natural (NK) without demonstrating direct toxic effect NK Thus, are adoptive immunocytotherapy, it may be useful characterize them functionally, vitro .

参考文章(21)
W.S. Peart, T.M. Andrews, J.I.S. Robertson, CARCINOID SYNDROME The Lancet. ,vol. 277, pp. 577- 578 ,(1961) , 10.1016/S0140-6736(61)92247-4
Vladimir von Fliedner, Catherine Barras, Michael Stoeck, Sylvia Miescher, Liang Qiao, Laurent Barrelet, Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Cancer Research. ,vol. 48, pp. 6992- 6998 ,(1988)
R. Cohen, Z. Steiner, A. Klajman, I. Bruderman, H. Rabinowich, Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Research. ,vol. 47, pp. 173- 177 ,(1987)
L Mesler Muul, PAUL J Spiess, ELAINE P Director, STEVEN A Rosenberg, Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. Journal of Immunology. ,vol. 138, pp. 989- 995 ,(1987)
Bijay Mukherji, M. T. Ergin, Amala Guha, R. Loomis, Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer. Journal of Immunology. ,vol. 138, pp. 1987- 1991 ,(1987)
S L Topalian, D Solomon, F P Avis, A E Chang, D L Freerksen, W M Linehan, M T Lotze, C N Robertson, C A Seipp, P Simon, Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. Journal of Clinical Oncology. ,vol. 6, pp. 839- 853 ,(1988) , 10.1200/JCO.1988.6.5.839
RichardL. Kradin, LenoraA. Boyle, FredericI. Preffer, RonaldJ. Callahan, Martha Barlai-Kovach, H.William Strauss, Steven Dubinett, JamesT. Kurnick, Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunology, Immunotherapy. ,vol. 24, pp. 76- 85 ,(1987) , 10.1007/BF00199837
R. Heimark, D. Twardzik, S. Schwartz, Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets Science. ,vol. 233, pp. 1078- 1080 ,(1986) , 10.1126/SCIENCE.3461562
U. Galili, F. Vanky, L. Rodriguez, Eva Klein, Activated T lymphocytes within human solid tumors Cancer Immunology, Immunotherapy. ,vol. 6, pp. 129- 133 ,(1979) , 10.1007/BF00205536